Ipamorelin 10mg

Researchers investigate peptide interaction and selectivity using ipamorelin in experimental settings. Selectivity refers to how specifically a peptide binds to certain molecular targets. Laboratory teams explore peptide behavior in controlled research models examining molecular interactions. Scientists study controlled experimental peptide systems under various laboratory conditions. Research groups examine how selective peptides function differently than non-selective compounds. These studies occur exclusively in research environments without clinical applications.

Ipamorelin is investigated in research environments for peptide interaction analysis. Scientists have studied this compound within controlled laboratory settings using established protocols. The formulation is explored for experimental peptide interaction research in academic facilities. Researchers evaluate the peptide under controlled conditions without outcome claims.

Store ipamorelin in cool, dry, light-protected conditions between 2-8°C. Light-protected storage means keeping vials away from direct sunlight and bright lights. This product is intended for laboratory handling only by qualified research personnel. Qualified personnel have received training in peptide reconstitution and handling techniques. Avoid moisture exposure as water content can affect peptide stability and purity. Avoid heat exposure above recommended temperature ranges to maintain structural integrity. Structural integrity refers to peptides maintaining their proper three-dimensional configuration. Reconstituted solutions should follow established laboratory storage guidelines for peptide research protocols.

Each ipamorelin batch undergoes comprehensive purity verification procedures through analytical methods. Analytical methods use scientific instruments to measure peptide composition and quality. Our processes ensure batch-to-batch consistency across all research supply orders. Internal quality assurance standards follow research-grade supply positioning for peptide compounds. Research-grade supply indicates products meet specifications for scientific laboratory use. Testing protocols verify peptide purity and structural characteristics using validated techniques. Every unit meets our specifications before receiving distribution approval. Laboratory certificates accompany each order for institutional tracking and compliance documentation.

• CAS: 170851-70-4
• Chemical Formula: C₃₈H₄₉N₉O₅
• Molecular Weight: 711.9 g/mol
• Peptide Sequence: Aib–His-D-2Nal-D-Phe-Lys
• Synonyms: Ipamorelin Acetate
• Shelf life: 24 months from the manufacturing date.

Ipamorelin is a synthetic peptide consisting of five amino acids in a specific sequence. This pentapeptide is manufactured for laboratory research applications across various fields. Pentapeptide means a peptide containing exactly five amino acid units. Selective interaction means the peptide preferentially binds to specific molecular receptors. Molecular receptors are protein structures that receive and respond to molecular signals. Selective peptides are studied in research because they help scientists understand targeted binding. Targeted binding examines how molecules attach to specific sites rather than multiple locations. Researchers investigate these interactions to understand fundamental molecular recognition processes. Molecular recognition describes how molecules identify and bind to appropriate partners.

Ipamorelin provides a synthetic research peptide formulation developed for scientific applications. Synthetic peptides are manufactured compounds created through chemical synthesis processes. Each batch undergoes high-purity testing to ensure compound consistency across orders. The formulation is designed for controlled laboratory environments conducting peptide selectivity research. Peptide selectivity research examines how peptides interact with specific molecular targets. Secure packaging with discreet shipment protects the peptide during transit to research facilities.

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue (GHS) that selectively activates the growth hormone secretagogue receptor (GHS-R1a, also known as the ghrelin receptor). It belongs to the GHS peptide class and is characterised in research models for its GH-releasing activity and its selectivity for GHS-R1a relative to other peptide hormones in the same receptor family.

Ipamorelin is notable among GHS peptides for its reported selectivity — in preclinical research models, it has been shown to stimulate GH release with minimal concomitant stimulation of cortisol, prolactin, or ACTH secretion at equivalent doses, distinguishing it from less selective GHS compounds such as GHRP-2 and GHRP-6. This selectivity profile makes it a useful pharmacological tool for studying GHS-R1a signalling in isolation.

GHS-R1a is a Gq-coupled GPCR. Ipamorelin binding activates phospholipase C, generating IP3 and diacylglycerol. IP3 releases calcium from the ER, and the resulting intracellular calcium transient is the primary second messenger driving GH secretion in somatotroph cells. In research, GHS-R1a activation by Ipamorelin is characterised using IP1 accumulation assays, calcium imaging, and arrestin recruitment BRET assays.

Primary pituitary cell preparations, somatotroph-derived cell lines, and GHS-R1a-transfected HEK293 or CHO cells are standard research systems for Ipamorelin pharmacology. In vitro concentration-response curves measuring IP1 accumulation or calcium mobilisation characterise receptor potency. Selectivity is assessed by profiling Ipamorelin against related receptors including GIPR and the motilin receptor, which share structural similarity with GHS-R1a.

Ipamorelin as supplied by Elivena is for research use in controlled laboratory settings only. It is not approved for human administration, therapeutic use, or performance enhancement outside of formally regulated clinical research programmes.